658 related articles for article (PubMed ID: 16203972)
1. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
Cha SH; Hu Z; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: Role of PGC-1alpha.
Cha SH; Rodgers JT; Puigserver P; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15410-5. PubMed ID: 17030788
[TBL] [Abstract][Full Text] [Related]
3. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
4. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
Thupari JN; Landree LE; Ronnett GV; Kuhajda FP
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9498-502. PubMed ID: 12060712
[TBL] [Abstract][Full Text] [Related]
5. Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation.
Bezaire V; Spriet LL; Campbell S; Sabet N; Gerrits M; Bonen A; Harper ME
FASEB J; 2005 Jun; 19(8):977-9. PubMed ID: 15814607
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
Hu Z; Cha SH; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12624-9. PubMed ID: 14532332
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3.
Cha SH; Hu Z; Lane MD
Biochem Biophys Res Commun; 2004 Apr; 317(2):301-8. PubMed ID: 15063757
[TBL] [Abstract][Full Text] [Related]
8. C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl CoA.
Yang N; Kays JS; Skillman TR; Burris L; Seng TW; Hammond C
J Pharmacol Exp Ther; 2005 Jan; 312(1):127-33. PubMed ID: 15356215
[TBL] [Abstract][Full Text] [Related]
9. Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs.
Schmidt I; Herpin P
J Nutr; 1998 May; 128(5):886-93. PubMed ID: 9566999
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
[TBL] [Abstract][Full Text] [Related]
11. Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation.
Bentebibel A; Sebastián D; Herrero L; López-Viñas E; Serra D; Asins G; Gómez-Puertas P; Hegardt FG
Biochemistry; 2006 Apr; 45(14):4339-50. PubMed ID: 16584169
[TBL] [Abstract][Full Text] [Related]
12. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
Alam N; Saggerson ED
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
[TBL] [Abstract][Full Text] [Related]
13. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
14. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552
[TBL] [Abstract][Full Text] [Related]
15. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
16. C75 activates malonyl-CoA sensitive and insensitive components of the CPT system.
Nicot C; Napal L; Relat J; González S; Llebaria A; Woldegiorgis G; Marrero PF; Haro D
Biochem Biophys Res Commun; 2004 Dec; 325(3):660-4. PubMed ID: 15541339
[TBL] [Abstract][Full Text] [Related]
17. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
[TBL] [Abstract][Full Text] [Related]
18. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.
Landree LE; Hanlon AL; Strong DW; Rumbaugh G; Miller IM; Thupari JN; Connolly EC; Huganir RL; Richardson C; Witters LA; Kuhajda FP; Ronnett GV
J Biol Chem; 2004 Jan; 279(5):3817-27. PubMed ID: 14615481
[TBL] [Abstract][Full Text] [Related]
19. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.
Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR
Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029
[TBL] [Abstract][Full Text] [Related]
20. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
